跳至主要内容
临床试验/NCT05876416
NCT05876416招募中不适用

Decoding the Genetic Landscape of Skeletal Diseases

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
450
试验地点
1
主要终点
New gene discoveries for genetic skeletal disorders (GSDs)

研究概览

简要总结

This 5-year project aims to (1) search for genetic causes for yet unsolved congenital skeletal disorders (GSDs); (2) study consequences of the newly identified pathogenic variants in cells and in transgenic mice, (3) summarize data on natural course and complications for different GSD groups. For patients with unsolved GSD, the investigators search for molecular causes of GSDs using whole genome sequencing (WGS) and total ribonucleic acid (RNA) sequencing. Candidate gene variants are selected using genome or transcriptome sequencing data, clinical findings and screening of omics databases. Causality of the new variants is studied in cells and in transgenic mice models. Molecular and clinical findings are summarized for different GSD groups.

详细描述

Genetic skeletal disorders (GSDs) are a large group of rare diseases caused by abnormalities in genes regulating skeletal development. This 5-year project aims to (1) search for genetic causes for yet unsolved congenital skeletal disorders; (2) study consequences of the newly identified pathogenic variants in cells and in transgenic mice, (3) summarize data on natural course and complications for different GSD groups. The project is a collaboration between the Dept of Clinical Genetics, Karolinska University Hospital, Lab of Clinical Genetics and Lab of Bone and Cartilage Physiology, Karolinska Institutet and Sahlgrenska Academy. In a well-characterized group of 300 GSD participants whose DNA samples were analyzed using whole genome sequencing (WGS), there are 120 study participants with unsolved diagnoses. For those participants, we search for molecular causes of GSDs using WGS and total RNA sequencing. Candidate gene variants are selected using genome or transcriptome sequencing data, clinical findings and screening of omics databases. Causality of the new variants is studied in cells and in transgenic mice models. Molecular and clinical findings are summarized for different GSD groups. Our results improve diagnostics for GSDs, advance knowledge on pathogenesis and help establishing new individual follow-up and treatment strategies for patients with GSDs. This project increases understanding of skeletal pathophysiology and will contribute to the development of novel treatment methods for skeletal diseases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinically suspected skeletal dysplasia based on previous investigations
  • Abnormal height
  • Radiographic abnormalities of the skeleton in addition to other syndromic features
  • Healthy relatives of the affected study participants

排除标准

  • No radiographic data available from clinical investigations
  • Suspected environmental or multifactorial causes

结局指标

主要结局

New gene discoveries for genetic skeletal disorders (GSDs)

时间窗: 2023-2028

2-3 new disease causes and disease entities identified and reported per year for GSDs.

Improved knowledge regarding natural cause of rare GSDs

时间窗: 2023-2028

1-2 GSDs reported as small patient groups with the same condition and clinical characteristics/course.

次要结局

  • Information on disease causing variants in GSD(2023-2028)
  • Disease (GSD) associated traits and complications(2023-2028)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giedre Grigelioniene

Associate Professor, MD, PhD

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验